Kolexia
Vivier Emmanuel
Anesthesie-réanimation
Centre Hospitalier Saint Joseph Saint Luc
Lyon, France
84 Activités
253 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Insuffisance respiratoire Syndrome de détresse respiratoire de l'adulte Broncho-pneumopathie chronique obstructive COVID-19 Maladie grave Maladies pulmonaires Bronchopneumopathies obstructives Obésité Hypoxie

Industries

MSD
1 collaboration(s)
Dernière en 2017
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

RECO-OHCA: REmote Ischemic COnditioning in Out-of-Hospital Cardiac Arrest: The RECO-OHCA Study
Essai Clinique (Hospices Civils de Lyon)   12 mars 2024
Ultra-portable Ultrasound vs. Standard Ultrasound to Help Place a Peripheral Catheter in Patients at Risk of Difficult Puncture
Essai Clinique (Centre Hospitalier Saint Joseph Saint Luc)   28 février 2024
Locked-in syndrome after central pontine myelinolysis, an outstanding outcome of two patients.
Annals of clinical and translational neurology   23 janvier 2024
COCCA: Low Dose of Hydrocortisone and Fludrocortisone in Adult Cardiogenic Shock. A Multicenter, Prospective, Double-blind, Randomized, Placebo-controlled Study
Essai Clinique (Hôpital Ambroise Paré)   03 novembre 2023
Shortening identification times: comparative observational study of three early blood culture testing protocols.
Frontiers in cellular and infection microbiology   18 juillet 2023
Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial.
JAMA internal medicine   07 juin 2023
190P Combination of IPH5201, a blocking antibody targeting the CD39 immunosuppressive pathway, with durvalumab and chemotherapies: Preclinical rationale
Abstract Book of the ESMO Immuno-Oncology Congress 2022 7-9 December 2022   01 décembre 2022
ANTICOVID: ANTIcoagulation in Severe COVID-19 Patients: a Multicenter, Parallel-group, Open-label, Randomized Controlled Trial
Essai Clinique (Assistance publique – Hôpitaux de Paris)   05 septembre 2022
High-flow nasal oxygen alone or alternating with noninvasive ventilation in critically ill immunocompromised patients with acute respiratory failure. A randomised controlled trial
Proceedings of Reanimation 2022, the French Intensive Care Society International Congress   22 juin 2022
Emmanuel Vivier | Témoignage d'un médecin en réanimation dans le cadre des Journées de l'UCLy
Youtube @ UCLy - Lyon Catholic University   17 mai 2022